BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4539360)

  • 21. Demonstration of the production of the long acting thyroid stimulator (LATS) by peripheral lymphocytes cultured in vitro.
    Wall JR; Good BF; Forbes IJ; Hetzel BS
    Clin Exp Immunol; 1973 Aug; 14(4):555-61. PubMed ID: 4201115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New in vitro tests to detect the thyroid stimulator in sera from hyperthyroid patients by measuring colloid droplet formation and cyclic AMP in human thyroid slices.
    Onaya T; Kotani M; Yamada T; Ochi Y
    J Clin Endocrinol Metab; 1973 May; 36(5):859-66. PubMed ID: 4349046
    [No Abstract]   [Full Text] [Related]  

  • 23. [LATS in Graves-Basedow disease].
    Nauman J; Nauman A
    Pol Arch Med Wewn; 1971; 46(3):315-21. PubMed ID: 5108058
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical and hormonal development of a case of malignant exophthalmus after hypophyseal myskiotomy].
    Stoica T; Arseni C; Constantinescu A; Coculescu M; Balmeş E
    Endocrinologie; 1977; 15(4):283-8. PubMed ID: 579476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis of Graves' ophthalmopathy without hyperthyroidism: long-acting thyroid stimulator (LATS) determination as laboratory adjunct.
    Gharib H; Mayberry WE
    Mayo Clin Proc; 1970 Jun; 45(6):444-9. PubMed ID: 4193249
    [No Abstract]   [Full Text] [Related]  

  • 26. The value of IgG separation for the detection of LATS in human serum.
    Bonnyns M; Vanhaelst L
    Clin Exp Immunol; 1969 May; 4(5):597-601. PubMed ID: 5815122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thyroid suppressibility and long-acting thyroid stimulator in thyrotoxicosis.
    Silverstein GE; Burke G
    Arch Intern Med; 1970 Oct; 126(4):615-20. PubMed ID: 4097002
    [No Abstract]   [Full Text] [Related]  

  • 28. Circulating inhibitor of LATS: a bioassay artefact.
    Burke G
    J Clin Endocrinol Metab; 1973 Jun; 36(6):1244-50. PubMed ID: 4740050
    [No Abstract]   [Full Text] [Related]  

  • 29. Relationship of long-acting thyroid stimulator to the clinical features and course of Graves' disease.
    Lipman LM; Green DE; Snyder NJ; Nelson JC; Solomon DH
    Am J Med; 1967 Oct; 43(4):486-98. PubMed ID: 6072779
    [No Abstract]   [Full Text] [Related]  

  • 30. LATS protector, the human thyroid stimulator.
    Adams DD
    N Z Med J; 1975 Jan; 81(531):22-3. PubMed ID: 1055310
    [No Abstract]   [Full Text] [Related]  

  • 31. [L.A.T.S. activity during hyperthyroidism. Apropos of 143 cases of Basedow's disease].
    Letonturier P; Tourneur R; Sénécal P
    Ann Med Interne (Paris); 1974 May; 125(5):463-7. PubMed ID: 4140703
    [No Abstract]   [Full Text] [Related]  

  • 32. Long-acting thyroid stimulator (LATS) in toxic nodular goitre, toxic adenoma and Graves' disease.
    Lamberg BA; Gordin A; Viherkoski M; Kvist G
    Acta Endocrinol (Copenh); 1969 Oct; 62(2):199-209. PubMed ID: 5394703
    [No Abstract]   [Full Text] [Related]  

  • 33. Validation of cytochemical section bioassay for thyroid-stimulating immunoglobulins in treated and untreated Graves' disease.
    Prentice MG; Alaghband-Zadeh J; Wise PH
    J Immunoassay; 1984; 5(3-4):275-90. PubMed ID: 6549396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [LATS(long-acting thyroid stimulator): recent development].
    Shishiba Y
    Naika; 1971; 28(1):48-52. PubMed ID: 4935654
    [No Abstract]   [Full Text] [Related]  

  • 35. [LATS and infiltrating ocular changes in Graves-Basedow's disease].
    Nauman J; Nauman A
    Pol Arch Med Wewn; 1972 Dec; 49(6):597-606. PubMed ID: 4678590
    [No Abstract]   [Full Text] [Related]  

  • 36. The long-acting thyroid stimulatory: is it of importance in Graves' disease.
    McKenzie JM; Zakarija M; D'Amour P; Joasoo A
    N Z Med J; 1975 Jan; 81(531):18-21. PubMed ID: 165442
    [No Abstract]   [Full Text] [Related]  

  • 37. Editorial: The latest of L.A.T.S.
    Lancet; 1974 Aug; 2(7878):443-4. PubMed ID: 4136681
    [No Abstract]   [Full Text] [Related]  

  • 38. ["Long-acting thyroid stimulator" (LATS)].
    Lamberg BA
    Duodecim; 1969; 85(20):1253-6. PubMed ID: 5396113
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of partial thyroidectomy for Graves' disease on serum long-acting thyroid stimulator protector (LATS-P).
    Hardisty CA; Talbot CH; Munro DS
    Clin Endocrinol (Oxf); 1981 Feb; 14(2):181-8. PubMed ID: 6894891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. L.A.T.S. and Graves' disease.
    Hedley AJ; Ross IP; Crooks J
    Lancet; 1970 Aug; 2(7670):468-9. PubMed ID: 4195146
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.